Britain believes that the vaccine, which Pfizer is co-developing with Germany’s BioNTech SE, could be ready to distribute before Christmas Officials in the British government expect that a verdict on whether Pfizer Inc-backed COVID-19 vaccine works will be available before the results are in on AstraZeneca Plc’s competing vaccine, it has been reported. Britain believes … Read more
Vow: Ben Osborn, the UK boss of Pfizer Ben Osborn is surprisingly chipper for a man carrying the hopes of a nation on his slim frame. The UK boss of pharmaceuticals behemoth Pfizer is champing at the bit to deliver the country the most unlikely Christmas present: a coronavirus vaccine. A jab developed by Pfizer, … Read more
US biotech firm Moderna, one of nine companies in the late stages of clinical trials for a Covid-19 vaccine, became the first to publish the complete blueprints of its study following calls for greater transparency. Pfizer, the other American company currently carrying out Phase 3 trials in the US, followed suit a short time later … Read more
Pfizer Inc says it could have results from its late-stage coronavirus vaccine trial available as early as October. On Thursday, CEO Albert Bourla said during a call sponsored by drug industry group International Federation of Pharmaceutical Manufacturers & Associations that 23,000 volunteers have been enrolled in the phase III trial, which began in July. The … Read more
Pfizer Inc signs multi-year deal to manufacture Gilead’s coronavirus antiviral remdesivir to boost production of the drug Pfizer Inc has signed a multi-year deal with Gilead Sciences Inc to manufacture and supply the antiviral remdesivir The drug is the only one approved in the US to treat coronavirus patients by emergency use after it was … Read more
German biotech BioNTech and US drugmaker Pfizer said on Monday they are launching a pivotal global study to evaluate their lead COVID-19 vaccine candidate. If the study is successful, the companies could submit the vaccine for regulatory approval as early as October, putting them on track to supply up to 100 million doses by the … Read more
Britain has signed deals with two foreign pharmaceutical giants for 90million doses of different experimental vaccines amid fears one of the world’s leading candidates won’t be ready by September — despite academics saying it could be ready for the autumn. Agreement has been reached for 30million doses from German firm BioNTech and Pfizer and 60million … Read more